The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Evidence review suggests digitally-supported HIV self-testing increases testing and engages first-time testers, paving the way for greater use
Experts are calling for healthcare for people with HIV to move beyond viral suppression to address long-term health and well-being
Avert CEO, Sarah Hand, discusses the importance of health literacy in the HIV response, and the positive potential of digital communications in achieving global HIV targets.
There’s been a lot of false information going around about COVID-19 vaccines, so it’s natural to have some questions. Here, we put the record straight with the key things you need to know.
Global evidence review finds wide variation on STI testing, despite people on PrEP being at greater risk of sexually transmitted infections.
Significant step as WHO recommends the dapivirine vaginal ring as a new HIV prevention tool following promising trial results
More than 10% of men who have sex with men, sex workers and prisoners with HIV have drug resistance when beginning treatment
Review initially finds dolutegravir has no links to birth defects then revises its findings to report a ‘slightly higher’ – but minimal – incidence after two cases emerge
Global survey finds a high proportion of people living with HIV know that ‘Undetectable = Untransmittable’ – and are more likely to be healthy compared to those who are unaware.
New 2025 targets aim to put the world back on track to end AIDS by 2030 following the news that Fast-Track targets were missed.